دانلود کتاب Vasculitis: From Diagnosis to Treatment

فهرست مطالب :

Contents Preface Chapter 1 Giant Cell Arteritis Abstract Introduction Epidemiology Pathology and Pathophysiology Signs and Symptoms Investigations Temporal Artery Biopsy Ultrasonography (USG) MRI PET Treatment Methotrexate Interleukin-Receptor Blocking Agents Tocilizumab Additional Comments on Treatment New Treatment Developments Conclusion Disclaimer References Chapter 2 Pulmonary Complications of Vasculitis Abstract Introduction Classification and Nomenclature Prevalence Pathophysiology Pulmonary Vasculitis Large-Vessel Vasculitis Giant Cell Arteritis 5.1.2. Takayasu Arteritis Medium-Vessel Vasculitis Polyarteritis Nodosa Kawasaki Disease Small-Vessel Vasculitis ANCA-Associated Vasculitis Granulomatosis with Polyangiitis Microscopic Polyangiitis Eosinophilic Granulomatosis with Polyangiitis Immune Complex Small Vessel Vasculitis Anti-Glomerular Basement Membrane Antibody Disease IgA Vasculitis Cryoglobulinemic Vasculitis Hypocomplimentemic Urticarial Vasculitis Variable-Vessel Vasculitis Behçet Disease Vasculitis due to Systemic Disease and Other Causes Necrotizing Sarcoid Granulomatosis Systemic Lupus Erythematosus-Related Vasculitis Rheumatoid Arthritis-Related Vasculitis Coronavirus Disease 2019-Related Vasculitis Drug-Induced Pulmonary Vasculitis Conclusion References Chapter 3 Eosinophilic Granulomatosis with Polyangiitis Abstract Introduction History Epidemiology Etiology Immune Dysfunction Genetic Factors Drug-Related Factors Pathophysiology Eosinophil Mediated Tissue Injury ANCA Mediated Tissue Injury Histopathology Clinical Presentation Organ System Involvement Upper Respiratory Tract and Pulmonary Manifestations Gastrointestinal Involvement Skin Involvement Renal Involvement Cardiovascular Involvement Neurologic Involvement Musculoskeletal Involvement Thromboembolic Disease Lymphadenopathy Investigations Initial Investigations Post-Diagnostic Evaluation Diagnosis Treatment Prognosis Conclusion References Chapter 4 Cardiovascular Complications of Vasculitis Abstract Introduction Pathophysiology of Complications in Vasculitides Large Vessel Vasculitis Giant Cell Arteritis Takayasu Arteritis Medium Vessel Vasculitis Polyarteritis Nodosa Kawasaki Disease Small Vessel Vasculitis Cryoglobulinemic Vasculitis Eosinophilic Granulomatosis with Polyangiitis Microscopic Polyangiitis Granulomatosis with Polyangiitis Variable Vessel Vasculitis Conclusion References Chapter 5 Cerebral Vasculitides Associated with Central Nervous System Herpesviridae Infection Abstract Introduction Pathophysiology Clinical and Imaging Manifestations of Herpes Virus Infection-Related Vasculopathy Herpes Simplex Virus 1 and 2 Varicella Zoster Virus Diagnosis of CNS Infection of Herpes Virus Herpes Simplex Virus 1 and 2 Varicella Zoster Virus Treatment Prognosis Conclusion References Chapter 6 Gastrointestinal Complications of Vasculitis Abstract Introduction Large-Vessel Vasculitis Medium-Vessel Vasculitis Small-Vessel Vasculitis Variable-Vessel Vasculitis Single-Organ Vasculitis Vasculitis Associated with Systemic Disease Clinical Presentation Diagnostic Evaluation Treatment and Management Conclusion References Chapter 7 Hypocomplementic Urticarial Vasculitis Syndrome Abstract Introduction Epidemiology Pathophysiology Clinical Presentation Cutaneous Manifestations Extra-Cutaneous Manifestations Joints Pulmonary Manifestations Renal Manifestations Gastrointestinal Manifestations Ocular Manifestations Cardiovascular Manifestations Neurologic Manifestations Diagnosis Management Prognosis Conclusion References Chapter 8 Pulmonary Capillaritis in Systemic Lupus Erythematosus Abstract Introduction Materials and Methods Selection of Patients Collection of Data Review of Literature Statistical Analyses Results Discussion Acknowledgments References Chapter 9 Cerebral Venous Sinus Thrombosis as a Complication of COVID-19 Vaccination Abstract Introduction Background CVST Excluding COVID-19 Epidemiology of CVST during COVID-19 Epidemiology of CVST/VITT after COVID-19 Infection Versus Vaccination Risk Factors for VITT/CVST Pathophysiology SARS-CoV-2 and Human Immune Response COVID-19 Vaccination and the Human Immune Response Adverse Effects of Vaccination Clinical Features of CVST Spectrum of Thromboses after Vaccination Management of VITT Diagnosis Treatment Future Research Conclusion References Index Blank Page Blank Page